Protect Animal Health Inc. (7850)

Overview

Protect Animal Health Inc. is a life science development company based in Taiwan, established in 2019. The company is focused on developing advanced healthcare solutions specifically for companion animals. Aiming to address critical unmet needs within the pet care market, particularly in cancer treatment, Protect Animal Health adapts proven human technologies to create therapeutic interventions for pets. Notably, the company utilizes recognized innovations such as the PD-1/PD-L1 immune-checkpoint inhibitors, which were awarded the Nobel Prize, to formulate novel therapeutic vaccines, like PT-001, thereby making immunotherapy more accessible for pets.

Boasting over fifty years of expertise in human drug development, Protect Animal Health is dedicated to combating age-related diseases along with exploring other high-potential avenues within companion animal health. The firm is known for its emphasis on developing drug pipelines that are tailored for pets, distinguishing its efforts from off-label uses of human medicines. Complemented by a leadership team rich in experience from elite institutions such as Harvard, Columbia, Cambridge, and major pharmaceutical firms including Boehringer Ingelheim and Merck, Protect Animal Health is supported by prominent investors committed to transforming the landscape of animal healthcare. Headquartered in Taipei, the company is pioneering innovation in the growing sector of companion animal therapeutics, with a vision to enable pets to enjoy longer and healthier lives.

Products and Services

• PT-001 Therapeutic Vaccine

  PT-001 is a groundbreaking therapeutic vaccine developed by Protect Animal Health, designed to utilize immune-checkpoint inhibitors that harness the power of the pet's immune system to combat cancer. This innovative approach adapts proven human technologies to create a targeted treatment tailored specifically for companion animals suffering from cancer, ultimately aiming to enhance their quality of life and improve survival rates.

• Customized Immunotherapy Solutions

  Beyond PT-001, Protect Animal Health offers customized immunotherapy solutions that cater to the specific health needs of different pets. These treatments are based on extensive research and development efforts that focus on the unique biological and physiological characteristics of companion animals, providing more effective and tailored therapeutic options.

• Drug Pipeline Development

  The company is dedicated to incubating a valuable pipeline of drugs aimed at addressing a range of conditions affecting companion animals, including chronic and age-related diseases. By leveraging their deep expertise in drug development, Protect Animal Health ensures that each product in their pipeline is designed with the utmost focus on the health and well-being of pets.

• Consultation and Support Services

  Protect Animal Health provides consultation services to veterinarians and pet owners about the best healthcare solutions available for their animals. This includes educational resources on emerging therapies, guidance on treatment options, and support throughout the treatment process to ensure that pet healthcare is well-informed and effectively managed.

• Research and Collaboration Opportunities

  As part of its commitment to innovation, Protect Animal Health seeks collaborations with research institutions, veterinary clinics, and other organizations aimed at advancing the field of veterinary medicine. Through these partnerships, the company aims to drive further research and development in novel therapeutic strategies for companion animals.